Leveraging Family Office Networks for Strategic Growth
Discover how Family Office Networks can enhance collaboration and investment opportunities.

Come join the Family Office Networks Webinar Series featuring Revance. Revance Therapeutics (NASDAQ: RVNC) is a Silicon Valley-based biotechnology company, pioneering new innovations in neuromodulators for aesthetic and therapeutic indications. Tobin Schilke, Chief Financial Officer and Dustin Sjuts, Chief Commercial Officer, Aesthetics & Therapeutics, will speak about the advantages of its next-generation neuromodulator, DaxibotulinumtoxinA for Injection, not only for wrinkle reduction, but also in the treatment of debilitating medical conditions.

Discover how Family Office Networks can enhance collaboration and investment opportunities.

Join the Family Office Networks Webinar Series Featuring Hemptown USA. Eric Gripentrog, CEO will discuss hemp derived cannabinoids, including CBD and CBG,…

Come Join the Family Office Networks’ Webinar Series featuring Asalyxa Bio. Asalyxa Bio’s elegant technology platform enables targeted delivery of therapeutic compounds…
Protected by reCAPTCHA — the Google Privacy Policy and Terms of Service apply.